Toss A - Search Results

1

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.

Canino F, Barbolini M, De Giorgi U, Fontana T, Gaspari V, Gianni C, Gianni L, Maestri A, Minichillo S, Moscetti L, Mura A, Nicoletti SVL, Omarini C, Pagani R, Sarti S, Toss A, Zamagni C, Cuoghi Costantini R, Caggia F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F. Canino F, et al. Among authors: toss a. BMC Cancer. 2024 Jun 15;24(1):735. doi: 10.1186/s12885-024-12506-0. BMC Cancer. 2024. PMID: 38879498 Free PMC article.

2

Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies.

Toss A, Venturelli M, Molinaro E, Pipitone S, Barbieri E, Marchi I, Tenedini E, Artuso L, Castellano S, Marino M, Tagliafico E, Razzaboni E, De Matteis E, Cascinu S, Cortesi L. Toss A, et al. Cancers (Basel). 2019 Feb 7;11(2):193. doi: 10.3390/cancers11020193. Cancers (Basel). 2019. PMID: 30736435 Free PMC article.

3

Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center (Italy).

Razzaboni E, Toss A, Cortesi L, Marchi I, Sebastiani F, De Matteis E, Federico M. Razzaboni E, et al. Among authors: toss a. Breast J. 2013 Jan-Feb;19(1):10-21. doi: 10.1111/tbj.12045. Epub 2012 Dec 17. Breast J. 2013. PMID: 23252601 Clinical Trial.

4

Hereditary ovarian cancer: not only BRCA 1 and 2 genes.

Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L. Toss A, et al. Biomed Res Int. 2015;2015:341723. doi: 10.1155/2015/341723. Epub 2015 May 17. Biomed Res Int. 2015. PMID: 26075229 Free PMC article. Review.

5

Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines.

Dullens B, de Putter R, Lambertini M, Toss A, Han S, Van Nieuwenhuysen E, Van Gorp T, Vanderstichele A, Van Ongeval C, Keupers M, Prevos R, Celis V, Dekervel J, Everaerts W, Wildiers H, Nevelsteen I, Neven P, Timmerman D, Smeets A, Denayer E, Van Buggenhout G, Legius E, Punie K. Dullens B, et al. Among authors: toss a. J Oncol. 2020 Jun 20;2020:9873954. doi: 10.1155/2020/9873954. eCollection 2020. J Oncol. 2020. PMID: 32655641 Free PMC article. Review.

6

Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework.

Tenedini E, Celestini F, Iapicca P, Marino M, Castellano S, Artuso L, Biagiarelli F, Cortesi L, Toss A, Barbieri E, Roncucci L, Pedroni M, Manfredini R, Luppi M, Trenti T, Tagliafico E. Tenedini E, et al. Among authors: toss a. Diagnosis (Berl). 2021 Jun 16;9(1):115-122. doi: 10.1515/dx-2021-0051. Diagnosis (Berl). 2021. PMID: 34142509

7

Twenty-years experience with de novo metastatic breast cancer.

Cortesi L, Toss A, Cirilli C, Marcheselli L, Braghiroli B, Sebastiani F, Federico M. Cortesi L, et al. Among authors: toss a. Int J Cancer. 2015 Sep 15;137(6):1417-26. doi: 10.1002/ijc.29503. Epub 2015 Mar 23. Int J Cancer. 2015. PMID: 25736070

8

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

Maur M, Toss A, Dominici M, Frassoldati A, Corradini P, Maiorana A, Fontana A, Conte P. Maur M, et al. Among authors: toss a. Am J Case Rep. 2015 Jul 3;16:424-9. doi: 10.12659/AJCR.893879. Am J Case Rep. 2015. PMID: 26140332 Free PMC article.

9

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?

Toss A, Venturelli M, Peterle C, Piacentini F, Cascinu S, Cortesi L. Toss A, et al. Int J Mol Sci. 2017 Jan 4;18(1):85. doi: 10.3390/ijms18010085. Int J Mol Sci. 2017. PMID: 28054957 Free PMC article. Review.

10

Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.

Omarini C, Bettelli S, Caprera C, Manfredini S, Caggia F, Guaitoli G, Moscetti L, Toss A, Cortesi L, Kaleci S, Maiorana A, Cascinu S, Conte PF, Piacentini F. Omarini C, et al. Among authors: toss a. Cancer Biol Ther. 2018;19(10):879-886. doi: 10.1080/15384047.2018.1480287. Epub 2018 Aug 1. Cancer Biol Ther. 2018. PMID: 30067438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters